We report a systematic review and meta-analysis of studies that assessed the antinociceptive efficacy of cannabinoids, cannabis-based medicines, and endocannabinoid …
As recreational use of cannabis is being decriminalized in many places and medical use widely sanctioned, there are growing concerns about increases in cannabis use disorder …
Cannabidiol (CBD) is increasingly used as analgesic medication although the recent International Association for the Study of Pain Presidential Task Force on cannabis and …
F Mestdagh, A Steyaert, P Lavand'homme - Current Oncology, 2023 - mdpi.com
Pain is frequently reported during cancer disease, and it still remains poorly controlled in 40% of patients. Recent developments in oncology have helped to better control pain …
F Petzke, T Tölle, MA Fitzcharles, W Häuser - CNS drugs, 2022 - Springer
Neuropathic pain represents a broad category of pain syndromes that include a wide variety of peripheral and central disorders. The overall prevalence of neuropathic pain in the …
Background and Purpose Cannabinoids are a promising therapeutic avenue for chronic pain. However, clinical trials often fail to report analgesic efficacy of cannabinoids. Inhibition …
The endocannabinoid system (ECS) is involved in various processes, including brain plasticity, learning and memory, neuronal development, nociception, inflammation, appetite …
Background Cannabis legalization has enabled increased consumption in older adults. Age- related mental, physical, and physiological changes may lead to differences in effects of …
P Bialas, MA Fitzcharles, P Klose… - European Journal of …, 2022 - Wiley Online Library
Abstract Background and Objective This systematic review evaluated the effectiveness, tolerability and safety of cannabis‐based medicines (CbMs) for chronic non‐cancer pain …